Startup Glycomine Lands $115M for Clinical Trial in Ultra-Rare Disease With No Approved Drugs

Glycomine’s lead program is an experimental treatment for PMM2-CDG, an ultra-rare enzyme deficiency often misdiagnosed as cerebral palsy. With encouraging results from an open-label Phase 2 study, the biotech startup is now preparing for a placebo-controlled test that could potentially support a regulatory submission. The post Startup Glycomine Lands $115M for Clinical Trial in Ultra-Rare…

Read More

Stay healthy—use your free preventive benefits

All Marketplace plans have free preventive benefits to help keep you healthy and avoid more serious illnesses. Talk with your doctor to figure out which services are right for you. Remember, services are only free if you get them from a provider in your plan’s network. Image What preventive services could I get? Some common services include:…

Read More